Source: San Francisco Business Times
Publication Date: July 3, 2014
A single-dose experimental cholera vaccine from passed a key test toward becoming the only vaccine for U.S. residents traveling abroad.
It’s an exciting time to join PaxVax. If you’re looking for an opportunity in healthcare to drive creativity, collaboration and innovation, we’d like to hear from you.